391510636	391510636	CD	B-NP	O
|	|	NN	I-NP	O
TH	TH	NN	I-NP	O
|	|	NN	I-NP	O
53130282	53130282	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7110415	7110415	CD	B-NP	O
|	|	CC	I-NP	O
10/13/2006	10/13/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
Emoblism	Emoblism	NNP	I-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/13/2006	10/13/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/8/2006	4/8/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
DELLUM	DELLUM	NN	B-NP	O
,	,	,	O	O
ERNIE	ERNIE	NN	B-NP	O
620-58-23-1	620-58-23-1	CD	I-NP	O
Lis	Lis	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
11/14/06	11/14/06	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
Attending	Attend	VBG	B-VP	O
evaluation	evaluation	NN	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
THWAITES	THWAITES	NNP	B-NP	O
,	,	,	O	O
ELLSWORTH	ELLSWORTH	NNP	B-NP	O
BERT	BERT	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
650	650	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q4H	Q4H	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Headache	Headache	NNP	I-NP	I-protein
DULCOLAX	DULCOLAX	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
BISACODYL	BISACODYL	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
5-10	5-10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Constipation	Constipation	NNP	I-NP	I-protein
COLACE	COLACE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
FLUTICASONE	FLUTICASONE	NNP	I-NP	O
NASAL	NASAL	NNP	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
2	2	CD	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
ADVAIR	ADVAIR	NNP	I-NP	O
DISKUS	DISKUS	NNP	I-NP	O
500/50	500/50	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
BID	BID	NN	I-NP	O
FONDAPARINUX	FONDAPARINUX	NN	I-NP	O
7.5	7.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
SC	SC	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/3/06	8/3/06	CD	B-NP	O
by	by	IN	B-PP	O
HALSTON	HALSTON	NNP	B-NP	O
,	,	,	O	O
DEWITT	DEWITT	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
HEPARIN	HEPARIN	NNP	B-NP	O
&	&	CC	I-NP	O
FONDAPARINUX	FONDAPARINUX	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	B-DNA
SINGULAIR	SINGULAIR	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
MONTELUKAST	MONTELUKAST	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
10	10	CD	I-NP	I-DNA
MG	MG	NN	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
BEDTIME	BEDTIME	NN	I-NP	I-DNA
NORTRIPTYLINE	NORTRIPTYLINE	NN	I-NP	I-DNA
HCL	HCL	NN	I-NP	I-DNA
10	10	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BEDTIME	BEDTIME	NNP	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	I-DNA
40	40	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BEDTIME	BEDTIME	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/4/06	10/4/06	CD	B-NP	O
by	by	IN	B-PP	O
SEITERS	SEITERS	NNP	B-NP	O
,	,	,	O	O
DORIAN	DORIAN	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
029241149	029241149	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7	7	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
NOW	NOW	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/2	3/2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
WITHIN	WITHIN	NN	B-NP	O
HOUR	HOUR	NN	I-NP	O
OF	OF	IN	B-PP	O
PHARMACY	PHARMACY	NNP	B-NP	O
APPROVAL	APPROVAL	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/4/06	10/4/06	CD	B-NP	O
by	by	IN	B-PP	O
LARISON	LARISON	NNP	B-NP	O
,	,	,	O	O
JACK	JACK	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
weight	weight	NN	B-NP	O
bearing	bear	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Banwarth	Banwarth	NNP	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
10/28/06	10/28/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
1	1	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Rehab	Rehab	NNP	B-NP	O
Center	Center	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NN	B-NP	O
,	,	,	O	O
Aspirin	Aspirin	NN	B-NP	O
,	,	,	O	O
NSAIDs	NSAID	NNS	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Pulmonary	Pulmonary	NNP	B-NP	O
Embolism	Embolism	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
Emoblism	Emoblism	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Asthma	Asthma	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
asthma	asthma	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Arthritis	Arthritis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
arthritis	arthritis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypercholesterol	hypercholesterol	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
elevated	elevated	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
GERD	GERD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
gastroesophageal	gastroesophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
obese	obese	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
knee	knee	NN	I-NP	O
repair	repair	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
knee	knee	NN	I-NP	O
surgery	surgery	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Chest	Ch	JJS	B-NP	O
CT	CT	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
SOB/Large	SOB/Large	NN	B-NP	O
Rt	Rt	NN	I-NP	O
main	main	JJ	I-NP	O
PE	PE	NN	I-NP	O
****	****	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
62yo	62yo	CD	B-NP	O
F	F	NN	I-NP	O
w/HTN	w/HTN	NN	I-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
s/p	s/p	NN	I-NP	O
L	L	NN	I-NP	O
total	total	JJ	I-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

Today	Today	NN	B-NP	O
she	she	PRP	B-NP	O
c/o	c/o	VBD	B-VP	O
pain	pain	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
with	with	IN	B-PP	O
deep	deep	JJ	B-NP	O
inspiration	inspiration	NN	I-NP	O
and	and	CC	I-NP	O
coughing	coughing	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
pain	pain	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
underwent	undergo	VBD	B-VP	O
surgery	surgery	NN	B-NP	O
on	on	IN	B-PP	O
4/5	4/5	CD	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
routine	routine	JJ	B-NP	O
post-op	post-op	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
only	only	RB	B-ADVP	O
received	receive	VBD	B-VP	O
routine	routine	JJ	B-NP	O
peri-operative	peri-operative	JJ	I-NP	O
prophylactic	prophylactic	JJ	I-NP	O
Abx	Abx	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
D/C	D/C	NN	B-NP	O
home	home	NN	I-NP	O
on	on	IN	B-PP	O
2/3	2/3	NN	B-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
readmitted	readmitte	VBN	I-VP	O
for	for	IN	B-PP	O
gastroenteritis	gastroenteritis	NN	B-NP	B-protein
6/5	6/5	CD	I-NP	I-protein
and	and	CC	O	O
sent	send	VBN	B-VP	O
home	home	NN	B-ADVP	O
without	without	IN	B-PP	O
Abx	Abx	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
and	and	CC	I-NP	O
home	home	NN	I-NP	O
PT	PT	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
5/19	5/19	CD	B-NP	O
after	after	IN	B-PP	O
3	3	CD	B-NP	O
weeks	week	NNS	I-NP	O
post-op	post-op	JJ	B-ADJP	O
however	however	RB	B-ADVP	O
her	her	PRP$	B-NP	O
INRs	INR	NNS	I-NP	B-protein
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
ROS	ROS	NN	B-NP	O
:	:	:	O	O
denies	deny	VBZ	B-VP	O
fevers	fever	NNS	B-NP	O
.	.	.	O	O

Continues	Continue	NNS	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
nausea	nausea	NN	B-NP	O
,	,	,	I-NP	O
vomiting	vomiting	NN	I-NP	O
and	and	CC	I-NP	O
diarrahea	diarrahea	NN	I-NP	O
.	.	.	O	O

But	But	CC	O	O
difficult	difficult	JJ	B-NP	O
to	to	TO	B-VP	O
fully	fully	RB	I-VP	O
assess	assess	VB	I-VP	O
b/c	b/c	NN	B-NP	O
entire	entire	JJ	I-NP	O
ROS	ROS	NN	I-NP	O
positive	positive	JJ	B-ADJP	O
per	per	IN	B-PP	O
patient	patient	NN	B-NP	O
.	.	.	O	O

Mostly	Mostly	RB	B-NP	O
c/o	c/o	NN	I-NP	O
pleuritic	pleuritic	JJ	I-NP	O
left	left	JJ	I-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	B-protein
LE	LE	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	O	O
ED	ED	VBN	B-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
PECT	PECT	NN	B-NP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
and	and	CC	I-NP	O
DVT	DVT	NN	I-NP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
Heparin	Heparin	NN	B-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
PMH	PMH	NN	B-NP	O
:	:	:	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
Asthma-no	Asthma-no	NNP	B-NP	O
intub	intub	NN	I-NP	O
,	,	,	O	O
past	past	JJ	B-NP	O
hosp	hosp	NN	I-NP	O
x2	x2	NN	I-NP	O
,	,	,	O	O
OA-s/p	OA-s/p	NN	B-NP	O
L	L	NN	I-NP	O
knee	knee	NN	I-NP	O
surg	surg	NN	I-NP	O
,	,	,	O	O
Hypercholestrolemia	Hypercholestrolemia	NN	B-NP	O
,	,	,	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
Cervical	Cervical	JJ	B-NP	O
and	and	CC	I-NP	O
thoracic	thoracic	JJ	I-NP	O
disc	disc	NN	I-NP	O
dz	dz	NN	I-NP	O
,	,	,	O	O
Fibromyalgia	Fibromyalgia	NNP	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
Meds	Med	NNS	B-NP	O
:	:	:	O	O
Cozaar	Cozaar	NNP	B-NP	O
100mg	100mg	CD	I-NP	O
QD	QD	NNP	I-NP	O
Nortriptyline	Nortriptyline	NNP	I-NP	O
10mg	10mg	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
HCTZ	HCTZ	NN	I-NP	O
25mg	25mg	NN	I-NP	O
QD	QD	NNP	I-NP	O
Atenolol	Atenolol	NNP	I-NP	O
75	75	CD	I-NP	O
QD	QD	NNP	I-NP	O
Lipitor	Lipitor	NNP	I-NP	O
40mg	40mg	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Singular	Singular	NNP	I-NP	O
10mg	10mg	NNP	I-NP	O
qHS	qHS	NNP	I-NP	O
Albuterol	Albuterol	NNP	I-NP	O
inh	inh	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Advair	Advair	NNP	I-NP	O
250/50	250/50	CD	I-NP	O
BID	BID	NNP	I-NP	O
Fluticasone	Fluticasone	NN	I-NP	O
nasal	nasal	JJ	I-NP	O
spray	spray	NN	I-NP	O
BID	BID	NNP	I-NP	O
Prilosec	Prilosec	NNP	I-NP	O
20mg	20mg	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Coumadin	Coumadin	NNP	I-NP	O
3mg	3mg	NN	I-NP	O
QD	QD	NNP	I-NP	O
Morphine	Morphine	NNP	I-NP	O
30mg	30mg	NN	I-NP	O
q12hr	q12hr	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Hydromorphone	Hydromorphone	NN	I-NP	O
2-6mg	2-6mg	NN	I-NP	O
q4-6hr	q4-6hr	NN	I-NP	O
PRN	PRN	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
All	All	DT	B-NP	O
:	:	:	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
cough	cough	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
ASA	ASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SOB	SOB	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
NSAIDS	NSAIDS	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GI	GI	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
FH	FH	NNP	I-NP	O
:	:	:	O	O
?	?	.	O	O

h/o	h/o	NN	B-NP	O
clot	clot	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
mother	mother	NN	I-NP	O
SH	SH	NN	I-NP	O
:	:	:	O	O
Tob	Tob	NN	B-NP	B-protein
:	:	:	O	O
none	none	NN	B-NP	O
.	.	.	O	O

EtOH	EtOH	NN	B-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
.	.	.	O	O

IVDU	IVDU	NN	B-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
Exam	Exam	NN	B-NP	O
:	:	:	O	O
98	98	CD	B-NP	O
83172/92	83172/92	CD	I-NP	O
18	18	CD	I-NP	O
93	93	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
FM	FM	NN	I-NP	O
NAD	NAD	NN	I-NP	O
,	,	,	O	O
AAOx3	AAOx3	NN	B-NP	B-protein
.	.	.	O	O

Non-icteric	Non-icteric	JJ	B-NP	O
,	,	,	I-NP	O
MMM	MMM	NN	I-NP	O
.	.	.	O	O

Supple	Supple	NNP	B-NP	O
.	.	.	O	O

CTA	CTA	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
B	B	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
BS	BS	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
RLL	RLL	NN	I-NP	O
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
nl	nl	NN	B-NP	B-protein
S1	S1	NN	I-NP	I-protein
S2	S2	NN	I-NP	I-protein
.	.	.	O	O

Soft	Soft	RB	B-ADVP	O
,	,	,	O	O
obese	obese	JJ	B-NP	O
BS	BS	NNP	I-NP	O
,	,	,	O	O
EXT	EXT	NNP	B-NP	O
:	:	:	O	O
Nontender	Nontender	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
palpable	palpable	JJ	I-NP	O
cords	cord	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
-LRB-	-LRB-	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
pedal	pedal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
leg	leg	NN	I-NP	O
-	-	HYPH	B-VP	O
ted	te	VBN	B-NP	O
stocking	stocking	NN	I-NP	O
and	and	CC	I-NP	O
TKR	TKR	NN	I-NP	O
bandages	bandage	NNS	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
-	-	HYPH	O	O
PECT	PECT	NN	B-NP	O
8/3	8/3	CD	I-NP	O
Rt	Rt	NN	I-NP	O
main	main	JJ	I-NP	O
pulm	pulm	NN	I-NP	O
artery	artery	NN	I-NP	O
PE	PE	NN	I-NP	O
extending	extend	VBG	B-VP	O
into	into	IN	B-PP	O
lovar	lovar	NN	B-NP	O
and	and	CC	O	O
subsegmental	subsegmental	JJ	B-NP	O
arteries	artery	NNS	I-NP	O
.	.	.	O	O

Small	Small	JJ	B-NP	O
PE	PE	NN	I-NP	O
LLL	LLL	NN	I-NP	O
subsegmental	subsegmental	JJ	I-NP	O
vessels	vessel	NNS	I-NP	O
.	.	.	O	O

Rt	Rt	NNP	B-NP	O
DVt	DVt	NNP	I-NP	O
LE	LE	NNP	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
8/3	8/3	CD	I-NP	I-protein
NSR	NSR	NN	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
RVH	RVH	NN	I-NP	B-protein
,	,	,	O	O
normal	normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
intervals	interval	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
S1Q3T3	S1Q3T3	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
Hospital	Hospital	NNP	B-NP	O
Course	Course	NNP	I-NP	O
:	:	:	O	O
62yo	62yo	CD	B-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	I-NP	O
asthma	asthma	NN	I-NP	O
and	and	CC	I-NP	O
recent	recent	JJ	I-NP	O
L	L	NN	I-NP	O
total	total	JJ	I-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
extensive	extensive	JJ	B-NP	O
PE	PE	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
extremely	extremely	RB	B-ADVP	O
SOB	SOB	NN	B-NP	B-protein
and	and	CC	O	O
c/o	c/o	NN	B-NP	B-protein
pleuritic	pleuritic	JJ	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
ekg	ekg	NN	I-NP	O
and	and	CC	I-NP	O
exam	exam	NN	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
anticoagulated	anticoagulate	VBN	I-VP	O
with	with	IN	B-PP	O
Heparin	Heparin	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
drop	drop	VB	I-VP	O
from	from	IN	B-PP	O
237	237	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
93	93	CD	B-NP	I-DNA
.	.	.	O	O

HIT	HIT	NN	B-NP	B-protein
was	be	VBD	B-VP	O
suspected	suspect	VBN	I-VP	O
and	and	CC	O	O
Heparin	Heparin	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Fondaparinux	Fondaparinux	NNP	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
PF4	PF4	NN	I-NP	B-protein
Antibody	Antibody	NN	I-NP	I-protein
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
pending	pende	VBG	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
after	after	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
Fondaparinux	Fondaparinux	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
intent	intent	NN	I-NP	O
to	to	TO	B-VP	O
bridge	bridge	VB	I-VP	O
over	over	RP	B-PRT	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
5	5	CD	I-NP	O
days	day	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
2-3	2-3	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
antihypertensives	antihypertensive	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
preload	preload	NN	B-NP	O
dependent	dependent	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
PE	PE	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
strain	strain	NN	I-NP	O
or	or	CC	O	O
LV	LV	NN	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EF	EF	NN	I-NP	B-protein
was	be	VBD	B-VP	O
65-70	65-70	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hospitalzation	hospitalzation	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
symptoms	symptom	NNS	I-NP	O
improved	improve	VBD	B-VP	O
dramatically	dramatically	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patients	patient	NNS	I-NP	O
respiratory	respiratory	JJ	I-NP	O
status	status	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
regiment	regiment	NN	I-NP	O
of	of	IN	B-PP	O
inhalers	inhaler	NNS	B-NP	O
and	and	CC	I-NP	O
nebulizers	nebulizer	NNS	I-NP	O
PRN	PRN	NN	I-NP	O
.	.	.	O	O

Ortho	Ortho	NNP	B-NP	O
evaluated	evaluate	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
while	while	IN	B-SBAR	O
hospitalized	hospitalize	VBN	B-VP	O
and	and	CC	O	O
recommended	recommend	VBD	B-VP	O
weight	weight	NN	B-NP	O
bearing	bear	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
narcotics	narcotic	NNS	B-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
TKR	TKR	NN	B-NP	B-protein
.	.	.	O	O

Heparin	Heparin	NN	B-NP	B-protein
products	product	NNS	I-NP	I-protein
should	should	MD	B-VP	O
be	be	VB	I-VP	O
avoided	avoid	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
PF4	PF4	NN	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
.	.	.	O	O

FULL	FULL	NN	B-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
notify	notify	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
continue	continue	VB	I-VP	O
your	your	PRP$	B-NP	O
Fonduparinox	Fonduparinox	NN	I-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Please	Please	NNP	B-NP	O
bridge	bridge	NNP	I-NP	O
Fondaparinux	Fondaparinux	NNP	I-NP	O
to	to	TO	B-PP	O
coumadin	coumadin	NN	B-NP	O
with	with	IN	B-PP	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
a	a	DT	B-NP	O
5	5	CD	I-NP	O
day	day	NN	I-NP	O
overlap	overlap	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
continue	continue	VB	I-VP	O
for	for	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
once	once	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
therpeutic	therpeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
with	with	IN	B-PP	O
INR	INR	NN	B-NP	O
2-3	2-3	NN	I-NP	O
.	.	.	O	O

11/14/06	11/14/06	CD	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
fourth	fourth	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
Fondaparinux	Fondaparinux	NN	B-NP	O
and	and	CC	O	O
third	third	JJ	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Monitor	Monitor	NN	I-NP	B-protein
INR	INR	NN	I-NP	I-protein
closely	closely	RB	B-ADVP	O
and	and	CC	O	O
platelet	platelet	NN	B-NP	O
count	count	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
LLERAS	LLERAS	NNP	B-NP	O
,	,	,	O	O
JERE	JERE	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CZ09	CZ09	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
11/14/06	11/14/06	CD	I-NP	O
@	@	SYM	B-NP	O
02	02	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

